This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Clinical Pharmacology Remove Organic Chemistry Related Topics
Computational Chemistry Protein Production Cell Biology Protein Expression Bioinformatics Immune Response Small Molecule Pharmaceuticals Therapies Treatment More Related Topics >
article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

JULY 4, 2023

Working in the CRO and CDMO environment she has led projects for customers across the globe, helping them to achieve their goals in clinical trials and low volume commercial manufacture. Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London. Clinical Pharmacology & Therapeutics.

Small Molecule 145
Small Molecule Drugs Clinical Pharmacology Trials 145
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

NOVEMBER 8, 2023

Adams, on a first-in-human study of ELU001, a targeted c’dot drug conjugate, in subjects with folate receptor α (frα) overexpressing solid tumours, and Groothuis on the non-clinical pharmacology of the MET-targeting ADC BYON3521.

Engineering 163
Engineering Protein Expression Therapies Science 163
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024